Retrieve Medical Holdings, Inc.
Data quality: 83%
RMHI
OTC
Manufacturing
Chemicals
$1.00
▲
$0.08
(8.34%)
Mkt Cap: 25.67 M
Price
$1.00
Mkt Cap
25.67 M
Day Range
$1.00 — $1.00
52-Week Range
$0.55 — $4.38
Volume
5
Open $1.00
50D / 200D Avg
$1.88
46.84% below
50D / 200D Avg
$1.51
33.90% below
Quick Summary
Key Takeaways
Negative free cash flow of -55,834.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-148.04%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current RatioN/A
Interest Coverage-8.84
Valuation
PE (TTM)
-117.85
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -117.9 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -217,856.0 |
| ROE | N/A | ROA | -184.18% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -55,834.0 |
| ROIC | -148.04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | -8.84 | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | -603,396 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -117.85 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.22% | ||
| Market Cap | 25.67 M | Enterprise Value | 25.67 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 25.63% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -164,969.0 | -76,089.0 | -15,011.0 | -13,993.0 | -28,407.0 |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -163,302.0 | -68,721.0 | -5,535.0 | -5,684.0 | -27,823.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 32,081.0 | 10,397.0 | 9,476.0 | 8,309.0 | 5,584.0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Total Assets | 130,349.0 | 261,152.0 | 408.0 | 527.0 | 2,270.0 |
| Total Liabilities | 621,503.0 | 587,337.0 | 250,504.0 | 235,612.0 | 223,362.0 |
| Shareholders' Equity | -491,154.0 | -326,185.0 | -250,096.0 | -235,085.0 | -221,092.0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | 0.0 | 0.0 | 0.0 |
| Current Assets | — | — | 408.0 | 527.0 | 2,270.0 |
| Current Liabilities | — | — | 250,504.0 | 235,612.0 | 223,362.0 |
{"event":"ticker_viewed","properties":{"ticker":"RMHI","listing_kind":"stock","pathname":"/stocks/rmhi","exchange":"OTC","country":"US"}}